BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 15104563)

  • 1. Thyroid autoantibody profiles in ophthalmic dominant and thyroid dominant Graves' disease differ and suggest ophthalmopathy is a multiantigenic disease.
    Goh SY; Ho SC; Seah LL; Fong KS; Khoo DH
    Clin Endocrinol (Oxf); 2004 May; 60(5):600-7. PubMed ID: 15104563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies.
    Eckstein AK; Plicht M; Lax H; Hirche H; Quadbeck B; Mann K; Steuhl KP; Esser J; Morgenthaler NG
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):612-8. PubMed ID: 15521965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The combination of absent thyroid peroxidase antibodies and high thyroid-stimulating immunoglobulin levels in Graves' disease identifies a group at markedly increased risk of ophthalmopathy.
    Khoo DH; Ho SC; Seah LL; Fong KS; Tai ES; Chee SP; Eng PH; Aw SE; Fok AC
    Thyroid; 1999 Dec; 9(12):1175-80. PubMed ID: 10646655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Significance of combining tests of thyroid autoantibodies in differential diagnosis between Graves's disease and Hashimoto's hyperthyroidism].
    Hu YM; Liu W; Lu GH
    Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):940-2. PubMed ID: 12899792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Estimation of anti-thyroid peroxidase autoantibody (TPOAb) and anti-thyroglobulin autoantibody (TgAb) in patients with various thyroid disease--comparison between histopathological findings and serological results in patients with Hashimoto's thyroiditis].
    Senda Y; Nishibu M; Kawai K; Mizukami Y; Hashimoto T
    Rinsho Byori; 1995 Dec; 43(12):1243-50. PubMed ID: 8569035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroid peroxidase and thyroglobulin auto-antibodies in patients with newly diagnosed overt hypothyroidism.
    Carlé A; Laurberg P; Knudsen N; Perrild H; Ovesen L; Rasmussen LB; Jorgensen T; Pedersen IB
    Autoimmunity; 2006 Sep; 39(6):497-503. PubMed ID: 17060029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical validity of anti-thyroperoxidase antibody and anti-thyroglobulin antibody].
    Lian XL; Bai Y; Sun ML; Guo ZS; Dai WX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Dec; 26(6):677-81. PubMed ID: 15663231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in thyroid function and immunological parameters long after subtotal thyroidectomy for Graves' disease.
    Kasuga Y; Kobayashi S; Fujimori M; Shingu K; Asanuma K; Hama Y; Ito K; Maruyama M; Amano J
    Eur J Surg; 1998 Mar; 164(3):173-8. PubMed ID: 9562276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy.
    Gerding MN; van der Meer JW; Broenink M; Bakker O; Wiersinga WM; Prummel MF
    Clin Endocrinol (Oxf); 2000 Mar; 52(3):267-71. PubMed ID: 10718823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance imaging determination of extraocular eye muscle volume in patients with thyroid-associated ophthalmopathy and proptosis.
    Kvetny J; Puhakka KB; Røhl L
    Acta Ophthalmol Scand; 2006 Jun; 84(3):419-23. PubMed ID: 16704711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between anti-human eye muscle antibodies and thyroid function, anti-TSH receptor antibodies and eye symptoms in Graves' ophthalmopathy.
    Molnár I; Balázs C
    Wien Klin Wochenschr; 1992; 104(24):744-7. PubMed ID: 1363165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency and characteristics of TBII-seronegative patients in a population with untreated Graves' hyperthyroidism: a prospective study.
    Vos XG; Smit N; Endert E; Tijssen JG; Wiersinga WM
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):311-7. PubMed ID: 18208575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-dependent cell-mediated cytotoxicity against orbital target cells in thyroid-associated ophthalmopathy and related disorders; close relationship between serum cytotoxic antibodies and parameters of eye muscle dysfunction.
    Barsouk A; Peele KA; Kiljanski J; Stolarski C; Nebes V; Kennerdell JS; Volpe R; Wall JR
    J Endocrinol Invest; 1996 Jun; 19(6):334-41. PubMed ID: 8844451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relevance of TSH receptor stimulating and blocking autoantibody measurement for the prediction of relapse in Graves' disease.
    Schott M; Minich WB; Willenberg HS; Papewalis C; Seissler J; Feldkamp J; Bergmann A; Scherbaum WA; Morgenthaler NG
    Horm Metab Res; 2005 Dec; 37(12):741-4. PubMed ID: 16372227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The quantitative measurement of autoantibodies to thyroglobulin and thyroid peroxidase by automated microparticle based immunoassays in Hashimoto's disease, Graves' disease and a follow-up study on postpartum thyroid disease.
    Gilmour J; Brownlee Y; Foster P; Geekie C; Kelly P; Robertson S; Wade E; Braun HB; Staub U; Michel G; Lazarus JH; Parkes AB
    Clin Lab; 2000; 46(1-2):57-61. PubMed ID: 10745983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limited usefulness of antithyroperoxidase and antithyroglobulin assays in Jamaicans with Graves' disease.
    Wright-Pascoe R; Smikle MF; Barton EN; James OB
    Hum Antibodies; 1999; 9(3):161-4. PubMed ID: 10690629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Distribution of IgG subclasses of TgAb and TPOAb in sera from patients with Graves' disease, Graves' disease plus Hashimoto's thyroiditis and Hashimoto's thyrotoxicosis].
    Yuan S; Yu N; Gao Y; Huang W; He Y; Dong B; Lu G; Li M; Cai X; Peng D; Wang Y; Li T; Huang Y; Gao Y; Guo X; Shi B
    Zhonghua Yi Xue Za Zhi; 2014 Jan; 94(2):110-4. PubMed ID: 24721350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A bioluminescence assay for thyrotropin receptor antibodies predicts serum thyroid hormone levels in patients with de novo Graves' disease.
    Hovens GC; Buiting AM; Karperien M; Ballieux BE; van der Pluijm G; Pereira AM; Romijn JA; Smit JW
    Clin Endocrinol (Oxf); 2006 Apr; 64(4):429-35. PubMed ID: 16584516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetylcholine receptor antibodies in patients with Graves' ophthalmopathy.
    Jacobson DM
    J Neuroophthalmol; 1995 Sep; 15(3):166-70. PubMed ID: 8574362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of circulating antibodies against double-stranded and single-stranded DNA with thyroid autoantibodies in Graves' disease and Hashimoto's thyroiditis patients.
    Pedro AB; Romaldini JH; Americo C; Takei K
    Exp Clin Endocrinol Diabetes; 2006 Jan; 114(1):35-8. PubMed ID: 16450315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.